The extension allows CME Group to continue offering futures, options on futures, and over-the-counter cleared products based on FTSE Russell indexes, including the Russell 1000, Russell 2000, FTSE Developed Europe, and FTSE China 50.
“We are very pleased to extend our licensing agreement and partnership with FTSE Russell,” said Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group.
“Our FTSE Russell futures and options have grown substantially over our decades-long partnership, offering clients deep liquidity and the potential for greater capital efficiencies when they trade across our equity complex.”
Fiona Bassett, CEO of FTSE Russell, said: “The continued growth in trading volumes across FTSE Russell-linked products reflects the strength of our indexes and the value they bring to investors looking to measure performance across the global equity market.”
Since their last renewal in 2015, more than 573 million FTSE Russell-linked contracts have traded on CME Group.
The exchange reported an average daily volume of 306,000 contracts this year across Russell futures and options, underscoring strong investor demand for transparent and efficient index-based exposure.
